Granules India’s Jeedimetla facility completed the US FDA inspection

Granules India’s Jeedimetla facility completed the US FDA inspection

Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).

FPJ Web DeskUpdated: Friday, June 23, 2023, 03:42 PM IST
article-image
Granules India’s Jeedimetla facility completed the US FDA inspection | Image: Granules (Representative)

Granules Jeedimetla facility located at Hyderabad, Telangana, India has successfully completed the US FDA’s surveillance inspection with zero observations, the company announced through an exchange filing. The inspection was completed between June 19 and June 23.

Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).

Granules shares

The shares of Granules on Friday closed at Rs 286.95, down by 0.35 per cent.

RECENT STORIES

National Pension Scheme: Key Features, Tax Benefits, And Eligibility Explained

National Pension Scheme: Key Features, Tax Benefits, And Eligibility Explained

EPFO Reports Highest Monthly Net Member Addition In December 2023

EPFO Reports Highest Monthly Net Member Addition In December 2023

High Security Registration Plates: Is It Mandatory? Everything You Need To Know From Application To...

High Security Registration Plates: Is It Mandatory? Everything You Need To Know From Application To...

Truce At Last, PayPal Registers With FIU Under Anti-Money Laundering Law

Truce At Last, PayPal Registers With FIU Under Anti-Money Laundering Law

Centre Mulls Setting Up Maritime Development Fund

Centre Mulls Setting Up Maritime Development Fund